NGF and metabolic syndrome: In contrast, Chaldakov et al. showed decreased levels of NGF in plasma samples from patients with metabolic syndrome and in the atherosclerotic coronary vessel wall, especially those with advanced lesions, confirming its involvement in the evolution of atherosclerotic plaques in T2DM [62, 63].